Intellectual Property

  • April 22, 2026

    Judge Lets AI Copyright Claims Against Databricks Proceed

    A California federal judge has denied a bid from software and artificial intelligence firms Databricks and Mosaic ML to escape authors' allegations that their works were used to train large language models, saying the proposed class of writers had asserted a sufficient complaint.

  • April 22, 2026

    Entegris Says Ex-Engineer Used Its Tech To Start Rival Firm

    Tech company Entegris says a former lead engineer secretly founded his own competing firm by stealing trade secrets and has been soliciting its customers, including Intel, to bring their business to his startup, according to a suit in Massachusetts state court.

  • April 22, 2026

    6th Circ. Questions Timing Of Late Keyboardist's Royalties Bid

    A Sixth Circuit panel sharply questioned both sides Wednesday over when, if ever, Parliament-Funkadelic co-founder George Clinton clearly rejected a decades-old royalty deal with the band's former keyboardist, signaling uncertainty about whether the late musician's estate waited too long to sue.

  • April 22, 2026

    Oura Hit With New Patent Suit Over Fitness Wearables

    Zepp Health has hit Oura Health with a lawsuit in the Eastern District of Texas accusing the Finnish company of infringing a series of patents on wearable fitness devices, the latest salvo in a wider patent fight between the companies.

  • April 22, 2026

    Norton Rose Faces $100M Suit Over Withdrawn Patent App

    Norton Rose Fulbright was sued in Illinois state court Tuesday by an advertising tech company claiming that the law firm mishandled a patent application and caused it to be deemed withdrawn, but kept the company in the dark about the loss of its valuable patent rights for over a year.

  • April 22, 2026

    Commure Took Health Co.'s Software Trade Secrets, Suit Says

    A San Diego-based healthcare technology services company has accused Commure Inc. of stealing trade secrets to launch competing cloud-based software, framing the alleged conduct as an instance of a large company "backed by big money" breaking the rules to obtain a much smaller competitor's information.

  • April 22, 2026

    Paint Co. Says Injury Firm Used Stolen Data To Solicit Clients

    A paint company has asked a North Carolina federal court to boot the opposing counsel in a putative data breach class action, accusing them of finding stolen data on the dark web and using it to solicit potential plaintiffs before victims were even notified of the breach.

  • April 22, 2026

    WIPO Head Gets Another Term To Lead UN Agency

    World Intellectual Property Organization Director General Daren Tang has been reappointed to the position after being nominated by its coordination committee earlier this year to again lead the United Nations agency.

  • April 21, 2026

    Anthropic Pushes Fair Use Defense In Music Cos.' IP Fight

    Anthropic PBC has asked a California federal judge to find that its use of copyrighted materials to train its tool Claude is "transformative" fair use under copyright law, comparing Claude's learning to how humans learn from reading and internalizing the themes of various works.

  • April 21, 2026

    Mariah Carey's Atty Fee Bid For IP Win 'Absurd,' Judge Told

    Singer Mariah Carey's bid for $600,000 in attorney fees after her Davis Wright Tremaine LLP attorneys defeated a copyright infringement ahead of trial is "absurd," the plaintiff's counsel told a California federal judge Tuesday, arguing that the amount is excessive for a successful summary judgment motion.

  • April 21, 2026

    IP Notebook: Global Copyright, ChatGPT TM, Rogers Test

    This round of Law360's look at emerging copyright and trademark issues includes a forthcoming U.S. Supreme Court appeal with global implications for copyrights, and OpenAI's setback in its effort to register "ChatGPT" as a trademark.

  • April 21, 2026

    Copyright Head Touts 6,000 Registrations Of Human-AI Works

    The U.S. Copyright Office has issued more than 6,000 registrations for works that incorporate artificial intelligence-generated materials and follow the agency's guidance for combined human-made and AI-created works, U.S. Copyright Office leader Shira Perlmutter said Tuesday.

  • April 21, 2026

    Archer, Joby Spar Over Claims In Battle To Gain Air Taxi Edge

    Archer Aviation has told a federal court that rival electric air-taxi company Joby Aviation cannot ditch counterclaims alleging Joby concealed its China-based sourcing and misclassified imports to evade tariffs, while Joby accuses Archer of riding its coattails and trying to reframe the narrative around its own shady dealings.

  • April 21, 2026

    Congress Rallies More For Bills On Copyrights Than Patents

    There have been more intellectual property bills floated in Congress that are supportive of copyright rights than patent rights, according to a new report looking at how lawmakers treat the IP system.

  • April 21, 2026

    Gaming Co. Escapes Blackjack IP Claims Over Pleading Gaps

    The owners of a trademarked blackjack game had its claims dismissed against gambling giant Penn Entertainment Inc. and one of its Colorado casinos after a federal judge found the claims alleging the casino illegally continued using the blackjack game for years after its license expired weren't sufficiently pled.

  • April 21, 2026

    Squires Hints At New 'Holistic' Decision On PTAB Discretion

    U.S. Patent and Trademark Office Director John Squires previewed at a conference Tuesday an imminent "comprehensive decision" that will articulate current policy on discretionary factors that inform the viability of Patent Trial and Appeal Board challenges, saying he's seeking "predictability" for the PTAB.

  • April 21, 2026

    WDTX Judge Albright Stepping Down At End Of Summer

    U.S. District Judge Alan Albright is resigning after nearly eight years presiding over cases in the Western District of Texas, Law360 confirmed Tuesday.

  • April 21, 2026

    Pfizer, Dexcel Take 2 Patents Off Table For Bench Trial

    Drugmaker Pfizer and an Israeli competitor that is seeking to create a generic version of a Pfizer heart medication said Tuesday they have reached an agreement to remove two asserted patents from a trial set to start next week.

  • April 21, 2026

    Fed. Circ. Keeps Banner Witcoff And Saiber Off Patent Case

    The Federal Circuit kept intact the disqualification of two law firms from a patent ownership fight on Tuesday, saying it had not been shown a district judge made a clear error in removing them.

  • April 21, 2026

    Fed. Circ. Backs Micron PTAB Win Over Axed Chip Patents

    The Federal Circuit on Tuesday refused to revive a pair of semiconductor chip patents that Micron Technology was accused of infringing in Idaho federal court, backing the Patent Trial and Appeal Board's findings that they were invalid.

  • April 21, 2026

    Monster Looking To Block Foreign Versions Of Energy Drinks

    Energy drink giant Monster accused numerous businesses of importing into the U.S. versions of its products intended only to be sold abroad, telling the International Trade Commission that the products are infringing Monster's trademarks by being sold without proper labels, the ITC said Tuesday.

  • April 21, 2026

    Domino's, Pizza Hut, Others Sued Over Mobile Order Patents

    Pizza restaurants and food delivery companies were sued in Texas federal court and accused of infringing five patents that cover technology for mobile ordering and payments.

  • April 21, 2026

    Fed. Circ. Won't Stay Ramey Sanctions, $171K Fee Bill

    The Federal Circuit on Tuesday denied patent litigator William P. Ramey III's attempt to stay a California court's order that he self-report to various disciplinary authorities that he was sanctioned for practicing law without a license, as well as pay a six-figure attorney fee award, pending an appeal.

  • April 21, 2026

    Squires Stands By Ending Skincare IPR Over ITC Overlap

    U.S. Patent and Trademark Office Director John Squires has shot down Sinclair Pharma Ltd.'s request to revive its challenge to Hydrafacial LLC's skin treatment patent, which the director had terminated based on related proceedings at the U.S. International Trade Commission.

  • April 21, 2026

    Joe Gibbs Racing's Fast-Track Trial Is 'Unrealistic,' Court Told

    Joe Gibbs Racing LLC's bid to set a November trial date in a trade secrets suit against former competition director Chris Gabehart and rival team Spire Motorsports is "aggressive and unrealistic," Gabehart has argued in asking to instead push the trial to May 2027.

Expert Analysis

  • Series

    Coaching Soccer Makes Me A Better Lawyer

    Author Photo

    Coaching youth soccer for my 7-year-old son's team has sharpened how I communicate with clients, prepare witnesses, work within teams and think about leadership, making me a more thoughtful and effective lawyer in many ways, says Joshua Holt at Smith Currie.

  • Winter Olympics Put The Spotlight On IP Issues

    Author Photo

    This year's Winter Olympics generated a handful of intellectual property controversies that highlight the key considerations that should be kept in mind when using creative works at sporting events, says attorneys at Squire Patton.

  • Series

    Law School's Missed Lessons: The Human Element

    Author Photo

    Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.

  • Avoid The Unexpected When Drafting License Agreements

    Author Photo

    The Delaware Court of Chancery's recent decision in Commave v. Zevrain raises several practice points for attorneys drafting commercial contracts, underscoring the importance of considering anti-assignment provisions, specific exclusions and potential carveouts when drafting license agreements or other commercial contracts, say attorneys at Hogan Lovells.

  • A Reliable Liability Shield For Government-Sponsored R&D

    Author Photo

    The Federal Circuit's decision in Arlton v. AeroVironment last month confirms that the Section 1498 liability-shifting framework applies well beyond production contracts, providing powerful assurance that contractors performing government-directed work are shielded from patent infringement liability, say attorneys at Morgan Lewis.

  • The Benefits Of Choosing A Niche Practice In The AI Age

    Author Photo

    As artificial intelligence becomes increasingly accessible, lawyers with a niche practice may stand out as clients seek specialized judgment that automation cannot replicate, but it is important to choose a niche that is durable, engaging and a good personal fit, says Daniel Borneman at Lowenstein Sandler.

  • Have Iconic Twitter Trademarks Been Abandoned?

    Author Photo

    A set of lawsuits concerning the status of X Corp.'s "Twitter" and "tweet" trademarks, which will potentially be considered abandoned in July, will provide instructive insights into how trademark owners can defend against abandonment claims, say attorneys at Bradley Arant.

  • Google's Scraping Suit Asks How Far DMCA Protections Go

    Author Photo

    A California federal court's decision in Google v. SerpApi will spotlight a long-developing judicial split over how to apply the Digital Millennium Copyright Act’s ban on circumventing a copyright holder’s access controls, an increasingly important point in litigation over web scraping and artificial intelligence training, say attorneys at Jenner & Block.

  • Trial Advocacy Lessons From 3 Oscar-Nominated Films

    Author Photo

    Several films up for best picture at this weekend’s Academy Awards provide useful tips for trial lawyers, from the power of a dramatic opening to the importance of pivoting when the unexpected happens, say attorneys at Robins Kaplan.

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • Patent Eligibility Bulletin: Steps To Consider As USPTO Shifts

    Author Photo

    Recent memoranda from the U.S. Patent and Trademark Office, along with some of the first patents issued under Director John Squires, indicate a recalibration of the subject matter eligibility landscape, signaling a renewed emphasis on concrete technological improvements and a potentially pro-AI stance, say attorneys at Banner Witcoff.

  • Opinion

    Fed. Circ. Must Bury Design Patent Doctrinal Zombies

    Author Photo

    After recently finding noninfringement in Range of Motion Products v. Armaid, the Federal Circuit must rehear the case to confront two troublesome doctrines of design patent law claim construction — feature filtration and claim verbalization — that have lingered for decades and intensified in recent years, say attorneys at McAndrews Held.

  • Why La. Ruling May Open NIL Deals For Int'l Student-Athletes

    Author Photo

    A Louisiana federal court's decision to deny a motion to dismiss in Poa v. Jaddou, a case over whether international student-athletes may engage in name, image and likeness deals, signals that courts are willing to challenge rigid interpretations of immigration law in light of modern collegiate athletics, say attorneys at Shook Hardy.

  • Weighing Confusion Claims In Shoes-NFL Steakhouse TM Suit

    Author Photo

    A recent New York federal infringement complaint by 1587 Sneakers against Patrick Mahomes and Travis Kelce's Kansas City steakhouse 1587 Prime confronts the thorny question of how much operating in different industries should factor into likelihood-of-confusion analysis and why consumer perception can matter most in trademark fights, says Nate Garhart at Spencer West.

  • Unique Issues Facing Brand-Compounder Patent Litigation

    Author Photo

    Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.